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ABSTRACT 
Quality management systems (QMS) are becoming a global paradigm especially in testing laboratories. A critical 
component of QMS in testing laboratories is the proper handling of in-coming samples to ensure that the 
integrity of such samples are not compromised in any way before the commencement of testing and assure the 
validity of the results received from testing units. The sample reception unit in the Central Registry of the Central 
Drug Control Laboratory (CDCL) of the National Agency of Food and Drug Administration and Control 
(NAFDAC), Nigeria, did not have a QMS in place. The methodology for instituting QMS involved reorganization 
of the unit, development of all working documents, training and retraining of all staff/team members, 
implementation of the new system and then conducting continuous monitoring and evaluation using predefined 
key performance indicators. The results clearly show that the implementation of a QMS in the Sample Reception 
unit of the Central Registry of the Central Drug Control Laboratory has greatly improved the overall effectiveness 
and efficiency of the unit. It has ensured that the integrity of incoming samples is not compromised before testing 
by the analytical units. This has led to increased trust and reliability of the test results and analytical reports 
produced by the Central Drug Control Laboratory of the National Agency for Food and Drugs Administration and 
Control of Nigeria. 
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Quality management systems are becoming a global 
paradigm. All processes/organizations are 
implementing the principles of quality management 
systems to improve the quality and efficiency of their 
work output. Most testing laboratories are in the 
forefront of implementing QMS. 
In most laboratories around the world, the handling 
of in-coming samples (e.g. biological specimen, 
chemical samples, raw materials or finished 
pharmaceutical products) all require appropriate 
care. These are to ensure that the integrity of the 
samples is not compromised in any way and assure 
the validity of the results received from testing units. 
Thus there is a general realization that the 
processes involved in the management of incoming 
samples are critical and should be under control if 
reliable results are to be obtained from testing. 
To this end, the World Health Organization (WHO), 
the International Organization for Standards (ISO) 
and most National Drug Regulatory Authorities have 
guidelines for the proper handling of in-coming 
samples to laboratories. 
A number of researches have been done in the area 
of handling biological specimens and chemicals of 
various types, however not much research has been 
done on the receipt of finished pharmaceutical 
products to pharmaceutical testing laboratories. 
 
Research Question/ Hypothesis 
Will the institutionalization of a quality management 
system in the Central Registry unit of the Central 
Drug Laboratory of NAFDAC improve the overall 
performance and quality of work of the unit? 
My hypotheses is that the institutionalization of a 
quality management system in the Central Registry 
unit of the Central Drug Laboratory of NAFDAC will 
improve its overall performance and quality of work. 
 
Significance of the Problem 
The Central Drug Control Laboratory has the 
enormous responsibility of assuring that the 
populace uses only quality, safe and efficacious 
medicines by making pronouncements on the quality 
and effectiveness of medicines after appropriate 
quality control checks. These quality control checks 
must be done following approved international 
standards. Third world countries like Nigeria is 
battling with the growing menace of spuriously 
labeled and fake medicines that lead to treatment 
failures, drug resistant disease, and deaths among 
the populace. Nigeria, with a population of over 190 
million people, has become a dumping ground for 
various manufacturers of medicinal product, 
especially from Asia. The populace must be 
protected from this menace by a strong and stringent 
regulatory body of which a quality control laboratory 
is part. Thus all analytical work done in the 
laboratory has impact on the overall healthcare 
system of the country. However its assessment 
process starts at the sample reception area of the 
central registry unit of the laboratory. If samples are 
not properly handled in accordance with international 
standards at this point, it invalidates all other 
processes of the laboratory ab-initio. It is an 
identified critical control point in the health care 
system of the country. It is therefore imperative that it 
must be structured to meet international standards 
for quality management systems. 
Also for the laboratory to attain and retain World 
Health Organization pre-qualification status, it has to 
implement quality management system in this unit 
RESULTS OF LITERATURE SEARCH 
The literature search revealed that there is a dearth 
of scholarly work in the area of receipt, handling and 
storage of pharmaceutical products prior to analysis 
in testing laboratories.  
However, a handful amount of work has been done 
in the area of handling and management of 
biological samples such as blood, urine etc. 
submitted to medical laboratories for testing. 
There are research works and papers on how to 
implement quality management systems in 
laboratories in general. A number of researches 
have also been done to assess the impact of 
implementing quality management systems in 
different processes. 
All the literature reviewed revealed that improper 
handling of incoming test samples has impact on the 
test results. 
The article ‘Effects of sample handling and storage 
on quantitative lipid analysis in human serum’ written 
by Zikovic et al revealed that ‘proper storage and 
handling of samples is paramount to retaining their 
informativeness’ (Zivkovic et al., 2009). The 
researcher explored the effects of various storage 
and handling conditions such as freeze-thaw, 
extraction state, and storage temperatures, prior to 
the quantification of density-based lipoprotein 





analyze the samples to eliminate any equipment 
sensitivity bias.  
Studies by other investigators have corroborated this 
finding. Harsten et al showed that the way blood 
samples are handled significantly affected the results 
of blood gas analysis (Harsten, Berg, Inerot, & Muth, 
1988). Kozikwoski et al studied “the effect of room 
temperature storage on the stability of compounds 
stored in DMSO”. The stability of approximately 7200 
compounds stored as 20-mM DMSO solutions under 
ambient conditions was monitored for 1 year. The 
compound’s integrity was measured by flow injection 
analysis using positive and negative electrospray 
ionization mass spectrometry. Each sample was 
assessed at the beginning of the study, after 12 
months of storage, and at a randomized time point 
between the initial and final time points of the study. 
The study showed a gradual decrease in the integrity 
of the compounds  (Kozikowski et al., 2003). The 
data obtained by Busch et al in their study of the 
impact of specimen handling and storage on 
detection of Hepatitis C virus RNA further confirms 
that well controlled sample handling and storage 
processes are important to the quality of results 
obtained from the quantitative analysis of blood 
samples from patients who were positive on anti-
HCV supplemental blood test (Busch, Wilber, 
Johnson, Tobler, & Evans, 1992). 
There are however, clear guidelines on the proper 
handling of in-coming finished pharmaceutical 
products tested at pharmaceutical control 
laboratories. The guidelines reviewed were  
1. World Health organization good practices for 
pharmaceutical quality control laboratories 
2. ISO/IEC 17025 - General requirements for 
the competence of testing and calibration 
laboratories 
Part 2, section 14 of the WHO guidelines gives clear 
directives for the proper handling of in-coming 
samples to pharmaceutical quality control 
laboratories. Samples received by the laboratory 
may be for compliance testing or for investigative 
testing. Samples for compliance testing include 
routine samples for control, samples suspected of 
not complying with the specifications or samples 
submitted in connection with a marketing 
authorization process (World Health Organization, 
2010). A properly filled test request form should 
accompany all samples. Samples should be checked 
for any damages and matched with the information 
on the test request forms. All samples should be 
logged into a computerized system and given unique 
identification numbers. Samples should be stored in 
accordance with their recommended storage 
conditions while awaiting forwarding to testing units. 
There should be proper segregation of samples to 
avoid cross contaminations (World Health 
Organization, 2010) 
Similarly, section 5.8 of the ISO/IEC 17025 - General 
requirements for the competence of testing and 
calibration laboratories expounded on the handling 
of test and calibration items. Section 5.8.1 states 
“The laboratory shall have procedures for the 
transportation, receipt, handling, protection, storage, 
retention and/or disposal of test and/or calibration 
items, including all provisions necessary to protect 
the integrity of the test or calibration item, and to 
protect the interests of the laboratory and the 
customer”(ISO, 2005). It also has requirements for 
unique identification of samples, segregation of 
samples to avoid cross contamination and 
maintenance of adequate records. 
These guidelines underscore the importance of 
appropriate handling of all incoming samples. Any 
discrepancies at this point will affect all the validity of 
the test results. Implementation of these guidelines 
is part of the institutionalization of quality 
management systems in a drug-testing laboratory. 
It is generally agreed in the literature that the 
implementation of quality management systems in 
any organization or process will lead to an 
improvement in the operational systems of that 
organization. The article “The Impact of ISO 9000 
Quality Management Systems on Manufacturing” 
attests to this. The research showed a significant 
improvement in the performance of certified 
companies (i.e. companies that have implemented 
ISO 9000 Quality Management Systems) over those 
that are not certified (Tufan, 2007). 106 small and 
medium sized companies were examined of which 
79 of them had implemented ISO 9000 standards. 
Melnyk Steven et al, in their study of assessing the 
impact of environmental management systems on 
corporate and environmental performance also 
supports this theory (Melnyk, Sroufe, & Calantone, 
2003). Their results shows that firms that have EMS 
and ISO 14001 certification have greater impact on 
performance than firms who do not. Hongyi in his 
research paper showed that there is a relationship 
between the implementation of TQM and ISO 
standards and an improvement in performance of 
the organization.(Hongyi, 2000). Other reseachers 
that support this idea are Kaynak Hale (Hale, 2003) 
and Rao et al (Rao, Ragu-Nathan, & Solis, 1997). 
Konovalova and Popova concluded that 
implementation of quality management systems in 





quality results in time frames agreed with the clients 
using accepted testing methods. This in turn leads to 
customer satisfaction (Konovalova & Popova, 2010). 
The literatures revealed that the successful 
implementation of any quality management system 
is dependent on the framework of the 
implementation process. It is important to formulate 
a sound implementation framework prior to the 
embarking on such a change. It will be important to 
take into cognizance the systems on ground in the 
organization and construct a stepwise 
implementation framework that will have positive 
impact on the system. (Yusof & Aspinwall, 2010). 
This thought is supported by studies conducted by 
Andiric and Massambu. They studied the 
improvement of laboratory quality in Tanzania. The 
study showed that the improvement plan consisted 
of formalized hands-on training under the 
Strengthening Laboratory Management Toward 
Accreditation program (SLMTA) that teaches the 
tasks and skills of laboratory management and 
provides the tools for implementation of best 
laboratory practice. (Andiric & Massambu, 2015). 
Other researchers that support this thought are Yao 
et al (Yao et al., 2010). Groucher et al, in their peer 
reviewed article - “A process approach to ISO/IEC 
17025 in the implementation of a quality 
management system in testing laboratories”, showed 
that implementation of quality management systems 





Design And Implementation 
It is a quantitative type of research using a 
retrospective-prospective study design. The 
following data sets will be collected- 
• Retrospective data- this is a quantitative 
secondary type of data that will be acquired 
from the audit reports before the 
intervention. We will extract the number and 
type of non-conformances of the unit. 
• Prospective data – it is a quantitative data. 
There are 2 sets of data that will be collected 
viz- 
▪ Measurement of KPIs 
▪ Number of non-conformances after the 
implementation of quality systems in the 
unit 
To implement quality systems in the sample 
reception area of the central registry unit, the 
following were done: 
• Restructuring of the unit to perform all its 
expected functions (Organograms, Job 
descriptions) 
• Development of all relevant quality 
documents (SOPs, Work Instructions, etc) 
• Training of all staff 
• Test run of the new SOPs 
• Review of the SOPs 
• Full deployment of the new system 
• Monthly evaluation of the new system using 
KPIs (clearly defined KPIs will be developed) 
• Periodic self-audits of the unit  
• Scheduled audits by the Quality Assurance 
Manager of the Central Drug Control 
Laboratory 











The implementation of quality management systems 
in the Sample reception unit was monitored using 
clearly defined KPIs outlined below 
1. 95% compliance in inputting all in-coming 
samples into the Electronic laboratory 
system of the Central Drug Control 
Laboratory within 72 hours 
2. 95% error free (right-first-time) entries of 
sample data logged into the Electronic 
laboratory system of the Central Drug 
Control Laboratory 
3. 70% reduction in the severity of non-
conformances from the Sample Reception 
unit  
4. The environment of the storage area of in-
coming samples should be monitored twice 
daily 
5. The percentage of samples damaged during 
handling at the sample reception area of the 
Central Registry should be less than 1% of 
the total number of samples received. 
RESULTS 
Statistical methods were used to analyze and 
present the data obtained from monitoring the 
implementation of quality management systems. The 
number and types of non-conformances observed 
from the various audits, before and after the 
implementation of the Quality Management System 
were compared.  
The KPIs measured were charted to determine 
whether there is continuous improvement in the 
system. The findings are presented below. 
 
Percentage of Samples Inputted into the 
System within 72hrs 
This parameter, or KPI, helps to measure the 
efficiency of the sample reception process, that is, 
how fast the unit is able to process samples and 
input their details on the Electronic lab. From the 
chart, it is clear that there was an initial increase in 
efficiency between the months of May (37%) to 
August (79%) and then a sharp decline in 
September (12.9%), followed by a moderate 
improvement in October (25.6%). The set criterion 
for this KPI is 95% compliance in inputting all in-
coming samples into the Electronic laboratory 
system of the Central Drug Control Laboratory within 
72 hours. This criterion was not met 
 
Table 1- Percentage of Samples inputted into the 
system within 72hrs 
Month Percentage of Samples Inputted 











Figure 1- Percentage of Samples inputted into the System Within 
72hrs. 
 
Percentage of Error Free (Right-First-
Time) Entries. 
This KPI seeks to measure the effectiveness of the 
unit in handling the sample receipt process. 
The chart shows a steady increase in the percentage 
of error free entries. At the beginning of the 
measurement of this KPI, there was a 90% error free 
entry. However as of October, we had a 98.14% 
error free entry. The set criterion for this KPI is 95% 
error free entries of sample data logged into the 
Electronic laboratory system of the Central Drug 
Control Laboratory.  The unit exceeded the set 
criterion. This implies that the unit is becoming more 






Table 2- Percentage of Error Free Entries 









Figure 2 Percentage of Error Free Entries. 
 
Number and Type of Non-Conformances 
This parameter is one of the true tests of the 
successful implementation of quality management 
systems. Konovalova and Popova stated that one of 
the main sources of information for the evaluation of 
the effectiveness of the implementation of quality 
management systems is reports from internal and 
external audits.  Audits usually highlight the areas 
where improvement is necessary and gives an 
indication of whether a system is improving 
(Konovalova & Popova, 2010). 
The chart shows that the total number of non-
conformances has steadily decreased between the 
WHO Assessment in 2006 and the WHO Peer audit 
in 2015. The audit of 2006 revealed 8 non- 
conformances while that of 2015 revealed only 3 
non-conformances in the sample reception unit. Also 
of note is that there is an 87.5% reduction in the 
number of major non-conformances between 2006 
and 2015. The set criterion for this KPI was a 70% 
reduction in the severity of (i.e major) non-
conformances. This singular KPI gives a clear 
indication of improvement in the performance of the 
sample receipt process. 
Table 3- Number and Type of Non-Conformances 
Type of Audit Number of Non-Conformances 




8 0 8 
Internal Audit 
by QA March 
2015 




1 2 3 
 
 











Percentage of samples damaged during 
handling 
This KPI is a measure of how carefully samples are 
handled as they are received into the laboratory. The 
chart indicates that there has been a steady 
decrease in the percentage of samples damaged 
during the sample receipt process. In May, when the 
monitoring began, 1.16% of the total numbers of 
samples received for that month were damaged 
during handling. However by October, it was a 0% 
record of damaged samples. This is a 100% 
improvement in this KPI. The set criterion for this KPI 
is the percentage of samples damaged during 
handling at the sample reception area of the Central 
Registry should be less than 1% of the total number 
of samples received. The unit has thus exceeded 
this set criterion 
 
Table 4- Percentage of Samples Damaged During 
Handling 















The findings presented above clearly show that there 
has been a general improvement in the performance 
of the Sample Reception unit. Almost all key 
performance indicators monitored during and after 
the implementation of the quality management 
system showed improvement. The most indicative 
KPI is the number and type of non-conformances 
observed during audits. The most recent audit of the 
sample reception unit, by WHO revealed only one 
major non-conformance and 2 minor non-
conformances. This is an 87.5% improvement over 
the first audit in 2006 where eight major non-
conformances were observed. 
A 98.14% error-free entries were achieved after the 
implementation of QMS as opposed to the 90% 
error-free entries observed before the 
implementation of QMS. The percentage of samples 
damaged during handling steadily declined to 0%. 
The environmental conditions of the storage location 
for incoming samples were closely monitored to 
ensure that the integrity of incoming samples are not 
compromised. 
However, the indicator for the monitoring of the 
efficiency of the unit, that is, the number of samples 
inputted within 72hours, did not show consistent 
improvement. This indicator was initially improving 
from 37% in May to 79% in August and then a sharp 
decline to 12.9% in September. Investigations into 
this observation showed that there are major 
deficiencies in the sample reception unit that has to 
be addressed. The first is that the unit does not have 
enough qualified and trained staff. The unit relies 
heavily on temporary staff to help it in its functions. 
Thus in the months where there was a sharp decline 
in the speed with which samples were inputted into 
the system, it was found that the unit did not have 
enough trained personnel to handle all its function. 
The second issue was that the unit did not have 
enough tools (e.g. high speed computers) to carry 
out its functions. 
These findings clearly show that the implementation 
of a quality management system in the Sample 
Reception unit of the Central Registry of the Central 
Drug Control Laboratory has greatly improved the 
overall effectiveness and efficiency of the unit. It has 
ensured that the integrity of incoming samples are 
not compromised before testing by the analytical 
units. This has led to increased trust and reliability of 
the test results and analytical reports produced by 
the Central Drug Control Laboratory of the National 






It can therefore be concluded that implementing 
QMS in the sample reception unit of a 
pharmaceutical control laboratories will lead to 
improved performance, reliable and accurate test 
results. 
It is suggested that the monitoring of these KPI 
should be continued. The scope of monitoring may 
be expanded to include more KPIs that will involve 
the whole Central Registry section and not just the 
sample reception unit 
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